tiprankstipranks
Trending News
More News >

James Schoeneck Insider Profile

4 Followers
James Schoeneck, President & CEO, Director at Assertio Therapeutics, holds 6.37K shares in Assertio Therapeutics (Ticker: ASRT), holds ― shares in AnaptysBio (Ticker: ANAB), holds 84.51K shares in Calidi Biotherapeutics (Ticker: CLDI).
tipranks
James Schoeneck

James Schoeneck
Assertio Therapeutics (ASRT)
President & CEO, Director

Ranked #2,542 out of 103,225 Corporate Insiders

Profitable Transactions

78%
7 out of 9 Profitable Transactions

Average Return

+57.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$591K
74.68%
24.45%
0.87%
0.00%
A breakdown of James Schoeneck's holdings

Insider Roles

FibroGen
(FGEN)
Director
Calidi Biotherapeutics
(CLDI)
Director
Assertio Therapeutics
(ASRT)
President & CEO, Director
AnaptysBio
(ANAB)
Director
Roles that James Schoeneck holds in companies

Most Profitable Insider Trade

Stock:
Assertio Therapeutics
(ASRT)
Rating:Informative Buy
Date:Aug 04, 2014 - Aug 04, 2015
Return:+180.00%
The most profitable trade made by James Schoeneck

James Schoeneck's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Assertio Therapeutics
Dec 27, 2016
President & CEO, Director
Uninformative Buy
$5.16K
AnaptysBio
Director
Calidi Biotherapeutics
Aug 25, 2025
Director
Informative Buy
150.00K
$144.52K
FibroGen
Jul 02, 2025
Director
Informative Buy
119.48K
$441.48K
List of latest transactions for each holding click on a transaction to see James Schoeneck's performance on stock

James Schoeneck insider profile FAQ

What is the percentage of profitable transactions made by James Schoeneck?
The percentage of profitable transactions made by James Schoeneck is 78%.
    What is the average return per transaction made by James Schoeneck?
    The average return per transaction made by James Schoeneck is 57.30%.
      What stocks does James Schoeneck hold?
      James Schoeneck holds: ASRT, ANAB, CLDI, FGEN stocks.
        What was James Schoeneck’s latest transaction?
        James Schoeneck latest transaction was an Uninformative Buy of ―.
          What was James Schoeneck's most profitable transaction?
          James Schoeneck’s most profitable transaction was an Informative Buy of ASRT stock on August 4, 2014. The return on the trade was 180.00%.
            What is James Schoeneck's role in Assertio Therapeutics?
            James Schoeneck's role in Assertio Therapeutics is President & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.